Evidence map›Paper›PMID 42434278›Full record

ArticleJournal of gastrointestinal oncology2026

Development of a prognostic prediction model incorporating

Zhiwei Sun, Ying Yang, Jing Yu, Youwu Shi, Jing Sun, Feng Du, Yanjie Xiao, Songlin Gao, Xiaodong Zhang, Jun Jia

Abstract read
In one paragraph

Article in Journal of gastrointestinal oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhiwei Sun *Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), the VIP-II Gastrointestinal Cancer Division of Medical Department, Peking University Cancer Hospital & Institute, Beijing, China.
Ying Yang *Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), the VIP-II Gastrointestinal Cancer Division of Medical Department, Peking University Cancer Hospital & Institute, Beijing, China.
Jing YuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), the VIP-II Gastrointestinal Cancer Division of Medical Department, Peking University Cancer Hospital & Institute, Beijing, China.
Youwu ShiKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), the VIP-II Gastrointestinal Cancer Division of Medical Department, Peking University Cancer Hospital & Institute, Beijing, China.
Jing SunKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), the VIP-II Gastrointestinal Cancer Division of Medical Department, Peking University Cancer Hospital & Institute, Beijing, China.
Feng DuKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), the VIP-II Gastrointestinal Cancer Division of Medical Department, Peking University Cancer Hospital & Institute, Beijing, China.
Yanjie XiaoKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), the VIP-II Gastrointestinal Cancer Division of Medical Department, Peking University Cancer Hospital & Institute, Beijing, China.
Songlin GaoKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), the VIP-II Gastrointestinal Cancer Division of Medical Department, Peking University Cancer Hospital & Institute, Beijing, China.
Xiaodong ZhangKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), the VIP-II Gastrointestinal Cancer Division of Medical Department, Peking University Cancer Hospital & Institute, Beijing, China.
Jun JiaKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), the VIP-II Gastrointestinal Cancer Division of Medical Department, Peking University Cancer Hospital & Institute, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Public transcriptomic and clinical data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO; GSE26886 and GSE161533) were analyzed to assess Results: Conclusions:

Indexed as

esophageal squamous cell carcinoma (ESCC)KDM1Bprognostic prediction modelproliferationtreatment response

Identifiers

PMID42434278
PMCPMC13350477

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.